Paclitaxel/ramucirumabGastrointestinal perforation and fatigue: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1801卷 / 1期

关键词：

D O I：

10.1007/s40278-020-77867-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[1] RamucirumabGastrointestinal perforation: case report
Reactions Weekly, 2022, 1910 (1) : 417 - 417
[2] NaloxegolIntestinal perforation and fatigue: 3 case reports
Reactions Weekly, 2020, 1825 (1) : 169 - 169
[3] Paclitaxel/ramucirumabFebrile neutropenia, gastrointestinal perforation and pneumonitis: 3 case reports
Reactions Weekly, 2021, 1845 (1) : 312 - 312
[4] Paclitaxel/ramucirumabThrombocytopenia and gastric perforation: 2 case reports
Reactions Weekly, 2019, 1771 (1) : 239 - 239
[5] NaloxegolIntestinal perforation and fatigue: 2 case reports
Reactions Weekly, 2023, 1943 (1) : 541 - 541
[6] Capecitabine/temozolomideBowel perforation and fatigue: 2 case reports
Reactions Weekly, 2018, 1683 (1) : 179 - 179
[7] BevacizumabIntestinal perforation: 3 case reports
Reactions Weekly, 2013, 1471 (1) : 13 - 13
[8] BevacizumabIntestinal perforation: 3 case reports
Reactions Weekly, 2024, 2023 (1) : 81 - 81
[9] DimeticoneCorneal perforation: 3 case reports
Reactions Weekly, 2007, 1182 (1) : 15 - 15
[10] Paclitaxel/topotecanPneumonitis: 3 case reports
Reactions Weekly, 2015, 1580 (1) : 285 - 285

← 1 2 3 4 5 →